Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Constipation × alvimopan × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1 Neoplasms 1 Ileus 1 Constipation 1

Interventions

tegaserod 3 naloxegol 2 oxycodone naloxone combination 1 alvimopan 1 Sennosides 1 Phenolphthalein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00331045 2015-09-02

Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2 Terminated

Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡